Kunming Pharmaceuticals Group (600422.SH) released its semi-annual performance report, with a net profit attributable to the parent company of 198 million yuan, a year-on-year decrease of 26.88%.

Financial news from Securities Times app: Kunyao Group (stock code: 600422.SH) released its 2025 half-year report. During the reporting period, the company achieved a revenue of 3.351 billion yuan, a year-on-year decrease of 11.68%; the net profit attributable to the shareholders of the listed company was 198 million yuan, a year-on-year decrease of 26.88%; the non-recurring net profit was 151 million yuan, a year-on-year decrease of 5.57%; and the basic earnings per share were 0.26 yuan.